Announced Wed, 15 Jul · 17:22 IST
CEO of material subsidiary Shilpa Biologicals resigns
SHILPAMED · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹644.65
prior close
₹644.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.3-0.5-1.3-1.7-3.9-2.9-0.8-5.0-6.3-3.7————
Up moveDown movePending
AI summary
Dr Sridevi Khambhampaty has resigned as Chief Executive Officer of Shilpa Biologicals Private Limited, a material subsidiary of Shilpa Medicare Limited. The company has informed the NSE about the resignation. No reason for the exit or details on a successor were provided in this disclosure.
Likely market impact
Leadership change at a material subsidiary can create short term uncertainty; investors should watch for a succession update and any business impact at Shilpa Biologicals.